Skip to main content
. 2021 Oct 25;12(1):e96–e107. doi: 10.1055/a-1678-3563

Table 2. Patient characteristics and comorbidities.

Case no. Age (y) G/P Conception BMI Race/ethnicity Comorbidities
1 30 2/1001 OI/GnTP/IUI 20.8 Caucasian None
2 27 1/0 OI/CC 26.7 Caucasian PCOS, seizure disorder on Lamictal
3 36 1/0 OI/CC/IUI 30.6 Caucasian Lupus on Plaquenil
4 32 2/1001 Spontaneous 23.0 Caucasian None
5 26 2/0010 Spontaneous 34.0 Caucasian/Asian Anxiety, depression
6 29 2/1001 OI/GnTP 22.6 Caucasian Chronic HTN
7 27 1/0 OI/CC 36.0 Caucasian None
8 35 2/1001 Spontaneous 31.6 White h/o Roux-en-Y, anemia, h/o gestational HTN
9 28 8/2052 OI/GnTP 28.2 White Migraine, PCOS with infertility
10 28 3/1011 Spontaneous 19.4 Arab-American h/o 2nd trimester IUFD (19 wk)
11 32 4/2012 Spontaneous 21.0 White h/o bilateral PE, h/o 2nd trimester IUFD (16 wk)
12 38 2/1001 IVF 22.9 Asian seizures on levetiracetam and lamotrigine
13 34 3/1011 COH/IUI 24.0 Caucasian None
14 33 1/0 IVF 21.0 Asian Asthma

Abbreviations: BMI, body mass index; CC, clomiphene citrate; COH, controlled ovarian hyperstimulation; GnTP, gonadotropin; h/o, history of; HTN, hypertension; IUI, intrauterine insemination; IUFD, intrauterine fetal demise; IVF, in vitro fertilization; OI, ovulation induction; PCOS, polycystic ovarian syndrome; PE, pulmonary embolism.